Proxy Results Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 11, 2024 at 10:00 a.m. Eastern Time, Incannex Healthcare Inc. (the "Company"), held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"), at the offices of the Company's outside legal counsel, Mintz, located at 919 Third Avenue, New York, NY 10022. Of the Company's 17,642,832 shares of common stock issued and outstanding and eligible to vote as of the record date of October 24, 2024, a quorum of 7,661,666 shares, or approximately 43.42% of the eligible shares, was present in person or represented by proxy. Each of the matters set forth below is described in detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on November 12, 2024. The following actions were taken at the Annual Meeting:

Proposal 1

Election of the following nominee as a director of the Company, to serve until the 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.

		Votes For			Votes Withheld			Broker Non-Vote
Peter Widdows			5,540,460				283,676				1,837,530

Proposal 2

Ratification of the appointment of Grant Thornton Audit Pty Ltd as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025.

Votes For		Votes Against		Votes Abstained		Broker Non-Vote
7,519,726		134,469		7,471		-

Proposal 3

Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of the Company's issued and outstanding common stock pursuant to an equity line of credit agreement with Arena Business Solutions Global SPC II, Ltd ("Arena Global"), dated September 6, 2024, including commitment fee shares and a warrant issued to Arena Global.

Votes For		Votes Against		Votes Abstained		Broker Non-Vote
5,694,614		122,754		6,768		1,837,530

Proposal 4

Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of the Company's issued and outstanding common stock pursuant to a securities purchase agreement with the purchasers set forth on the signature pages therein (the "Purchasers"), dated September 6, 2024, including upon the conversion of debentures issued or issuable to Purchasers and upon the exercise of debenture warrants issued or issuable to Purchasers.

Votes For		Votes Against		Votes Abstained		Broker Non-Vote
5,689,790		127,578		6,768		1,837,530

Proposal 5

Approval of a postponement or adjournment of the Annual Meeting, from time to time, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to adopt the proposals set forth above or to establish a quorum.

Votes For		Votes Against		Votes Abstained		Broker Non-Vote
7,280,429		379,829		1,408		-

Public link

Please use the above public link if you want to share this noodl on another website.